The prevalence of right ventricular failure after ~rthotopic heart transplantation, evaluated in 196 patients, was 11.7%, as assessed by the presence during the first postoperative month of right atrial pressure >.10 mmHg. Two deaths, related to refractory right ventncular failure, were observed within the first month, both in subjects with preoperative pulmonary arteriolar resistances > 5 Wood Units. The haemodynamic profile a(fter heart transplantation showed a significant decrease ~ < 0.01) and an early normalization of pulmonary artenal pressure, pulmonary wedge pressure and pulmonary arteriolar resistances, while right atrial pressure slowly decreased until the third month. In a long-term analysis of s~rv.i~al (death within 1 year) the probability of death was stgntftcantly related to the values of right atrial pressure and cardiac index during the first month after heart translantation. Otherwise, the presence of elevated values of n?ht atrial pressure did not show a significant correlation ~Ith the echocardiographic right ventricular end-diastolic b •ameter nor with the presence of right bundle branch lock. The careful selection of patients referred for the c~rdiac transplantation (mean value of pulmonary artelar resistances in the evaluated subjects was 2.5 ± 1.5 ood Units) improves the probability of avoiding the ap-peara~ce of severe right ventricular failure in the postoperative period in most cases. The best predictor of right ventricular failure remains to be clearly identified. ~eY.words: Right ventricular failure-Pulmonary hyperelnston -Pulmonary vascular resistances -Heart transp antation !he development of secondary pulmonary hypertension ~s .~ frequent finding in patients with advanced cardiac 0~\~r e referred for heart transplantation. The evaluation e degree of pulmonary hypertension and pulmonary --~t ;eti~S~S to:vascular resistances is a critical issue in defining the indication for orthotopic cardiac transplantation. Previous experience in transplantation of patients with high pulmonary resistances has resulted in donor right heart failure generally in the early postoperative period.It is still unclear which among the various preoperative haemodynamic parameters indicative of pulmonary hypertension is a good predictor of the clinical and haemodynamicevolution after cardiac transplantation.The purposes of this study were to verify the prevalence of right ventricular failure after cardiac transplantation, to characterize the potential predictors of right ventricular failure after cardiac transplantation, and to evaluate the short-term (1 and 3 months) and long-term (1 year) mortality after heart transplantation in relation to the haemodynamic parameters before and after the cardiac transplant. Between November 1985 and April 1991, 196 orthotopic cardiac transplants were performed at the IRCCS Policlinico S. Matteo of Pavia, according to the criteria of the clinical programme of heart transplantation.
MethodsThe patients ranged from 9 to 67 years of age (mean age 43.2); 176 were males and 20 ...
SUMMARYThe authors have described two brothers, both affected by epidermolysis bullosa, struck at the same time by poliomyelitis anterior acuta having identical paralytic manifestations concerning the lower limbs and an almost reversed asymmetrical affection concerning the muscular groups of the upper limbs. Owing to the presence of a congenital desease, the Authors have considered the existence in the above mentioned brothers of a particular predisposition also for poliomyelitic infection.
SUMMARYThe Authors have reported five twin-pairs, two of which DZ and three MZ, all affected by poliomyelitic paralysis, affirming the existence of a particular predisposition to this disease and even of a local predisposition in MZ pairs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.